Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Financial Statements
- Click here to download Abiomed Inc.'s Income Statement
- Click here to download Abiomed Inc.'s Balance Sheet
- Click here to download Abiomed Inc.'s Statement of Cash Flows
Key Info
- Industry: Surgical and Medical Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Michael Minogue
Key Statistics
- Stock Price: $325.52
- Dividend Yield: 0%
- Market Capitalization: $14,953,240,576
- Shares Outstanding: 45,380,233
- Number of Employees: 1,725
- Trailing 12-Month EPS: $3.39
- Trailing 12-Month DPS: $0
- Payout Ratio: 0.0%
Important Dates
- Next Earnings Date: 2021-10-28
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $325.52
- 52-week high: $387.4
- 52-week low: $242.73
- 200-day moving average: $321.08
- 50-day moving average: $350.5
Performance
- 1-Month Price Return: -8.1%
- 3-Month Price Return: 5.2%
- 6-Month Price Return: 7.8%
- 1-Year Price Return: 20.9%
- 2-Year Price Return: 87.3%
- 5-Year Price Return: 156.6%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast